Navigation Links
Adding An Additional Drug May Help Patients With Glaucoma

Adding the drug latanoprost, also known as Xalatan, to conventional drugs used to treat the most common form of glaucoma can help reduce dangerous pressure // in the eye that leads to blindness.

Researchers conducted their study among 380 patients with open-angle glaucoma or another form of glaucoma known as exfoliation glaucoma who had originally used the drug in another three-year study. All elected to remain on the drug for another two years so investigators could continue to monitor the safety and effectiveness of the treatment.

Results of the study showed most patients had no increase in iris pigmentation over the five-year period. However, a subgroup of 127 patients, mostly with an eye color known to be susceptible to color change, did see changes in pigmentation. Patients affected by the change were mainly those with two different colors in their irises, such as green-brown or yellow-brown. However the pigmentation changes stabilized over time and patients who experienced pigmentation changes had no more adverse events than those without pigmentation changes and the drug was also found to be just as effective in reducing ocular pressure in patients with pigmentation changes as it was in those without, lowering ocular pressure by about 25 percent.

Thus researchers conclude saying that latanoprost therapy is infact a safe and well tolerated option for long-term treatment of open-angle glaucoma.
'"/>




Page: 1

Related medicine news :

1. Adding contrast improves ultrasounds ability to detect prostate cancer
2. Adding Fish to Diet May Reduce Risk of Alzheimers
3. Adding Credit To The Health Care Industry In India
4. Adding Sorghum Compounds To Dietary Supplements May Help Lower Cholesterol
5. Adding more fiber in the diet can offset hemorrhoids.
6. Trans Fats Adding Inches to the Waistline
7. Replacing Old Mattress, Adding Ventilation Reduces Mites
8. Adding Radiation Therapy For Treatment of Advanced Prostate Cancer May Offer Benefit
9. Additional Radiotheraphy for Breast Cancer
10. Additional Responsiblities To Be Taken Up By Allied Healthcare Professionals
11. No More Additional Cases of Mad Cow Disease in Canada
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 ... skin cancer deaths. More than 10,000 people are expected to die of melanoma this year. ... is the one of the most commonly diagnosed cancers in young women. A recent breakthrough ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that Boston ... and neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its ... is a newly patented safety device secured by nasal surgeons onto the floor ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Dairy Products, Inc. in an upcoming episode, airing third quarter 2016 via Discovery ... churning cream into butter, Grassland Dairy Products, located in Greenwood, Wisconsin applies product ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at HRC Fertility/Orange County ... Dr. Daniel A. Potter -- are proud of the recent release of their 2014 ... April, SART published the latest verified data for 375 U.S. member clinics. ...
(Date:4/29/2016)... ... 29, 2016 , ... International Dehydrated Foods, Inc. (IDF™) will attend and sponsor ... the Doubletree by Hilton Hotel in Oak Brook, Illinois. The two-day event is the ... protein ingredients. , At the seminar, IDF™ will offer samples of its Savory ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , Net Sales of $1.90 billion represent an increase ... period, and an increase of 1.2% on an adjusted pro ... first quarter were $0.52 reported, a decrease of 47.5% from ... 29.9% over the prior year period , The Company ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ...
(Date:4/28/2016)... April 28, 2016  ValGenesis, Inc., the ... Solutions (VLMS) today announced that a prominent ... sufferers of chronic kidney failure has selected ... their corporate validation process. The global medical ... solution to manage their validation processes electronically. ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 /PRNewswire/ ... des Sachs CEO Forums in Zürich gab ... ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung des ... eingesetzt wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie ... und Frankreich angeworben. STR001 wird während der ...
Breaking Medicine Technology: